Doctors currently rely on behavioral scales and imaging to identify disorders of consciousness (DoC) following brain injuries. However, these methods can sometimes be difficult to use consistently or may not provide a clear enough picture of a patient's condition. This review looks at how biological markers—specifically proteins, metabolites, and microRNAs—could offer a more precise way to diagnose these patients.
The research highlights that while many different types of biomarkers are being studied, they are currently in various stages of testing. Some are still in early exploration, while others are moving toward validation. Because the findings vary across different studies, no single biomarker has been proven as a definitive clinical tool just yet.
These findings suggest a need for more biologically-based tools to help doctors better understand patient progress. While these markers show promise for improving how we track recovery and predict outcomes, they are not yet ready to replace current standard care. Patients and families should continue to work with their medical teams to navigate the complexities of brain injury recovery.
